Skip to main content
Premium Trial:

Request an Annual Quote

Roswell Biotechnologies: Mike Aicher

Roswell Biotechnologies, a company developing single-molecular analysis platforms based on semiconductor chip technology, has appointed Mike Aicher as chairman of its board of directors. Aicher was president and founder of Alveo Technologies, an infectious disease testing startup. He cofounded and served as CEO of the National Genetics Institute (which became part of LabCorp in 2000) for more than two decades. He is also an executive director at Genetic Signatures, chairman of CytoBay, and a member of Techcyte's board of directors. Aicher previously served on the board of directors for Fabric Genomics, and was a board member of Ariosa until its acquisition by Roche.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.